US 8993752
Neprilysin inhibitors
granted A61KA61K31/415A61K31/4155
Quick answer
US patent 8993752 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/4178, A61K31/422